Get the latest Soma (Carisoprodol) shortage update for 2026. Learn what's causing supply issues, which manufacturers are affected, and what to do.
If you rely on Soma (Carisoprodol) to manage acute musculoskeletal pain, you may have noticed that filling your prescription has become more difficult. In this article, we'll give you the latest information on the Soma shortage in 2026, explain what's happening behind the scenes, and share practical advice for getting your medication.
As of early 2026, Carisoprodol availability remains inconsistent across the United States. While Soma is not currently listed as an active shortage on the FDA's official drug shortage database, many patients are reporting difficulty filling prescriptions at their regular pharmacies.
This type of situation — where a drug isn't in an "official" shortage but is still hard to find — is common with controlled substances. The supply is technically adequate at the national level, but distribution is uneven, leaving some areas well-stocked and others with limited access.
Several factors are contributing to the ongoing difficulty in finding Soma:
As a Schedule IV controlled substance, the amount of Carisoprodol that can be manufactured in the United States each year is regulated by the Drug Enforcement Administration (DEA). These quotas are designed to prevent overproduction and diversion, but they can also constrain supply during periods of increased demand or distribution issues.
The number of companies producing generic Carisoprodol has decreased over the years. The original brand-name Soma is largely discontinued, and the remaining generic manufacturers include companies such as Mylan, Sun Pharma, Teva, and Par Pharmaceutical. When any of these manufacturers experience production delays, the impact is felt more broadly because there are fewer alternatives to fill the gap.
Even when Carisoprodol is being manufactured, getting it from the factory to your local pharmacy involves a complex supply chain. Wholesalers may allocate limited quantities to individual pharmacies, and some pharmacies may receive smaller shipments than they need.
An increasing number of pharmacies — particularly large chain pharmacies — have implemented stricter policies around stocking controlled substances. Some locations may carry reduced quantities of Carisoprodol or choose not to stock it at all due to concerns about diversion and regulatory scrutiny.
Carisoprodol is available in two strengths: 250 mg and 350 mg tablets. The 350 mg strength is more commonly prescribed and is generally more widely stocked. However, availability issues can affect both strengths.
There is also a combination product containing Carisoprodol with Aspirin and Codeine, though this is rarely prescribed and even harder to find.
Use MedFinder to search for pharmacies near you that currently have Carisoprodol in stock. This is often the fastest way to find your medication without spending hours on the phone.
For a step-by-step approach, read our guide on how to find Soma in stock near you.
Don't wait until you're out of medication to start looking. Contact your pharmacy at least 5-7 days before you need a refill. If they don't have it, this gives you time to search other pharmacies or work with your doctor on alternatives.
You don't have to use the same pharmacy every time. If your regular pharmacy is consistently out of Soma, it may be worth establishing a relationship with a second pharmacy — especially an independent one — that can more reliably fill your prescription.
Keep your prescriber informed about the supply issues you're experiencing. They may be able to:
If you're paying out of pocket for Carisoprodol, prices can vary significantly between pharmacies. Check our guide on how to save money on Soma in 2026 for coupons, discount programs, and patient assistance options.
The Soma supply situation is likely to remain somewhat unpredictable throughout 2026. The factors driving the shortage — DEA quotas, fewer manufacturers, and cautious pharmacy stocking — are not expected to change quickly.
However, there are reasons for cautious optimism. Generic Carisoprodol remains on the market from multiple manufacturers, and the drug is still actively produced. The issue is more about distribution and access than a true production halt.
We will continue to update this article as new information becomes available. Bookmark this page and check back for the latest Soma shortage updates.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
